Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.

Nikpour M, Harvey PJ, Ibanez D, Gladman DD, Urowitz MB.

Arthritis Rheum. 2012 Sep;64(9):3052-3. doi: 10.1002/art.34541. No abstract available.

2.

High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk.

Barnes EV, Narain S, Naranjo A, Shuster J, Segal MS, Sobel ES, Armstrong AE, Santiago BE, Reeves WH, Richards HB.

Lupus. 2005;14(8):576-82.

PMID:
16175928
3.

Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?

O'Neill SG, Isenberg DA, Rahman A.

Ann Rheum Dis. 2007 Aug;66(8):989-91. No abstract available.

4.

Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus.

Lee SS, Singh S, Magder LS, Petri M.

Lupus. 2008 Feb;17(2):114-23. doi: 10.1177/0961203307085878.

PMID:
18250134
5.

Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus.

Nikpour M, Gladman DD, Ibañez D, Urowitz MB.

Lupus. 2009 Oct;18(11):966-73. doi: 10.1177/0961203309105130.

PMID:
19762397
6.

Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.

Karadag O, Calguneri M, Atalar E, Yavuz B, Akdogan A, Kalyoncu U, Bilgen SA, Ozer N, Ertenli AI, Ovunc K, Kiraz S.

Clin Rheumatol. 2007 May;26(5):695-9.

PMID:
16909327
7.

Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.

Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C.

Rheumatology (Oxford). 2003 Jun;42(6):758-62.

8.

Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients.

Zineldeen DH, Keshk WA, Ghazy AH, El-Barbary AM.

Ann Clin Biochem. 2016 Mar;53(Pt 2):240-51. doi: 10.1177/0004563215578190.

PMID:
25732129
9.

High-sensitivity C-reactive protein is not a good indicator of infection in patients with systemic lupus erythematosus.

Amezcua-Guerra LM.

Lupus. 2011 Dec;20(14):1567-8. doi: 10.1177/0961203311420748. No abstract available.

PMID:
21965276
10.

Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Becker GJ, Waldburger M, Hughes GR, Pepys MB.

Ann Rheum Dis. 1980 Feb;39(1):50-2.

11.

Cardiovascular risk and lupus disease.

Boucelma M, Haddoum F, Chaudet H, Kaplanski G, Mazouni-Brahimi N, Rezig-Ladjouze A, Brouri M, Berrah A.

Int Angiol. 2011 Feb;30(1):18-24.

PMID:
21248669
12.

The relationship between C-reactive protein and systemic lupus erythematosus.

Lauter SA, Espinoza LR, Osterland CK.

Arthritis Rheum. 1979 Dec;22(12):1421. No abstract available.

PMID:
518730
14.

Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.

Mok CC, Wong CK, To CH, Lai JP, Lam CS.

Arthritis Care Res (Hoboken). 2011 Jun;63(6):875-83. doi: 10.1002/acr.20440.

15.

Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?

Rezaieyazdi Z, Sahebari M, Hatef MR, Abbasi B, Rafatpanah H, Afshari JT, Esmaily H.

Lupus. 2011 Dec;20(14):1494-500. doi: 10.1177/0961203311418706.

PMID:
21993388
16.

Impact of cardiovascular events on residual renal function during the first year of peritoneal dialysis.

Coronel F, Pérez-Flores I, Calvo N, Martínez-Villaescusa M, Cigarrán S.

Perit Dial Int. 2007 Jul-Aug;27(4):454-6. No abstract available.

17.

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events.

Torres JL, Ridker PM.

Curr Opin Cardiol. 2003 Nov;18(6):471-8. Review.

PMID:
14597888
18.

Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis.

Hamidou MA, Audrain MA, Masseau A, Agard C, Moreau A.

Clin Rheumatol. 2006 Jul;25(4):542-3.

PMID:
16525896
19.

Periodontal disease as a risk factor for cardiovascular disease: suggestion of a further link in systemic lupus erythematosus.

Pessoa L, Galvão V, Santos-Neto L.

Med Hypotheses. 2011 Aug;77(2):286-9. doi: 10.1016/j.mehy.2011.04.037. Review.

PMID:
21601991
20.

High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.

Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH.

Lupus. 2011 May;20(6):588-97. doi: 10.1177/0961203310393378.

PMID:
21436216
Items per page

Supplemental Content

Support Center